NEURO NEWS
Neurological News with information about conditions, treatments, current studies and breakthroughs.
Quick Harmony: Transform Your Life with Short TMS Sessions
**Interviewer:** Dr. Khademi, thank you for joining us today. Can you start by explaining what Transcranial Magnetic Stimulation (TMS) is [...]
TMS Therapy for Aphasia at Countryside Neurology
Background: Aphasia, a condition affecting one-third of stroke patients, often presents a considerable challenge with limited improvements. This study, sourced [...]
Enhancing Post-Stroke Cognitive Function with Innovative TMS Therapy
Background: Post-stroke cognitive impairment (PSCI) can be a challenging condition, yet promising interventions like intermittent theta burst stimulation (iTBS) have [...]
Beyond Memory Loss: TMS Therapy’s Promise for MCI Patients
Mild Cognitive Impairment (MCI) stands as a critical crossroads between normal aging and the daunting progression towards Alzheimer's disease (AD). [...]
Discover the Potential of TMS Therapy for Mild Cognitive Impairment (MCI) at Countryside Neurology in Palm Harbor, FL
Transcranial magnetic stimulation (TMS) is gaining recognition as a promising non-invasive therapy for individuals grappling with mild cognitive impairment (MCI), [...]
🍂🦃 Happy Thanksgiving from Countryside Neurology! 🦃🍂
As the holiday season approaches, we want to take a moment to express our heartfelt gratitude. We are thankful for [...]
- Medicinal Signaling Cell Therapy Fast Tracked for Mild Alzheimer Disease July 29, 2024The investigational allogeneic cellular therapy is believed to impart anti-inflammatory, pro-vascular, and pro-regenerative effects.
- Endo Recalls Clonazepam ODT Due to Carton Label Displaying Incorrect Strength July 29, 2024The product is being recalled because the incorrect strength of 0.125mg is appearing on the carton labels.
- Investigational Gene Therapy for Parkinson Disease Gets Fast Track Status July 22, 2024AB-1005 is an investigational gene therapy based on AAV2 containing the human GDNF transgene.
- FDA Approves Aflibercept Biosimilar Ahzantive July 16, 2024Ahzantive is a vascular endothelial growth factor inhibitor.
- Ketamine May Reduce Cluster Headache Symptoms July 2, 2024Researchers sought to evaluate ketamine as a potentially promising treatment approach.
Get Social